Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01037478. IPD Sharing: Not stated. Countries: 3. Publications: 0.
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003578. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00244946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03681561. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
ClinicalTrials.gov study NCT00842114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
ClinicalTrials.gov study NCT06170489. IPD Sharing: NO. Countries: 1. Publications: 0.
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase I
ClinicalTrials.gov study NCT06835530. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Therapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03369964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00587015. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
ClinicalTrials.gov study NCT02983097. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
ClinicalTrials.gov study NCT06970496. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
ClinicalTrials.gov study NCT00002488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas
ClinicalTrials.gov study NCT01786018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
ClinicalTrials.gov study NCT06365671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06209619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00052416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )
ClinicalTrials.gov study NCT07032324. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT00944905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT06343311. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.